Search Results 651-660 of 13287 for Uvetils
intravitreal aflibercept (2.0 mg) every 4 weeks. SCORE2 aims to determine if bevacizumab is non-inferior to aflibercept for the treatment of macular edema ...
Additionally, to compare the effectiveness of axicabtagene ciloleucel versus SOCT, as measured by progression-free survival (PFS) and overall survival (OS).
About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...
The aim of this project is to evaluate whether kidney biopsy tissue will stain positive for C3d under immunofluorescence in patients who had renal thrombotic ...
The purpose of this study is to determine safety of plasma infusion in APOE 44 patients. Participation eligibility. Participant eligibility includes age, gender ...
The purpose of this study is to evaluate the effectiveness of different methods of culturing vaginal fibroblasts, and to test different biomarkers and probes on ...
The primary purpose of this study is to evaluate the effectiveness of REGN3500 monotherapy compared with placebo treatment in adult patients with moderate-to- ...
About this study. The purpose of this study is to see if there is a subjective improvement in operative time, incision length, volume of tissue removed and ...
The purpose of this study is to determine what factors predict poor surgical outcomes, and the extent to which patient-centered outcomes differ between ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.